Medical Packaging Inc., LLC (MPI) – Company News
At Medical Packaging Inc., LLC (MPI), we are always working to stay at the forefront of our industry in terms of technology, standards, guidelines, and more. We always have something new and exciting happening for our company. Please explore the news posts listed below to learn more about our latest company news, recent trends in our industry, new product offerings, and much more.

The landscape of healthcare in the United States often feels as intricate and complicated as the human body itself. In recent times, one of the greatest challenges stirring concern among professionals and patients alike has been the drug shortages of 2024. These shortages have broad-reaching implications, affecting everything from the supply chain management of pharmaceuticals to the availability of lifesaving, critical drugs for patients in need.

Much has changed and continues to evolve in clinical trials since the advent of artificial intelligence. Artificial intelligence (AI) — the simulation of human intelligence in machines — has become an instrumental force in modern healthcare. It is rapidly transforming the landscape of clinical research, especially in the processes related to clinical trials.

In the fast-paced consumer goods industry, one innovation is quietly reshaping how we think about packaging: Smart Packaging.
Smart packaging integrates science and technology to create packaging solutions that use digital identifiers to monitor product quality and track a package’s journey. Smart packaging of consumer goods is used in food and beverage, retail, automotive, electronics, and medical industries.

Prescription drug manufacturers often produce medications on a large scale. Pharmaceutical repackagers then acquire these medications in bulk and repackage them for distribution across diverse pharmacy markets within the healthcare industry.

In the rapidly evolving landscape of medicine, artificial intelligence (AI) stands at the forefront, revolutionizing the way we approach healthcare and drug development. The integration of AI technologies in the pharmaceutical industry marks a significant shift towards more efficient, accurate, and innovative practices, particularly in drug discovery and patient care.

A Drug Master File (DMF) is a confidential document submitted to the U.S. Food and Drug Administration (FDA) containing detailed information about facilities, processes, or articles used in the manufacturing process, packaging, and storing of one or more human drugs. This is crucial in the regulatory process as it allows for a comprehensive review of the drug product, ensuring that it meets all the necessary regulatory requirements for safety, quality, and efficacy.

In the world of pharmaceuticals, there is a constant effort to provide patients with more affordable alternatives to brand-name medications. Two terms that often come up in this context are “biosimilars” and “generic drugs.” Both biosimilar and generic drugs are unbranded versions of existing medications offered at lower costs.

The pharmaceutical industry has made great strides in the past few decades with the development of new medications and technologies for the treatment of different diseases. When it comes to packaging and shipping of pharmaceutical products, the considerations for supply chain are elevated along the way. Pharmaceutical transportation must be efficient and compliant with stringent safety standards to ensure the quality of products is not compromised.

Pharmacy automation is the electronic process of sorting, packaging, distributing, and counting prescription medications. Automation has revolutionized nearly every aspect of the pharmacy industry, from how prescriptions are filled, and packaged to how inventory is managed, how patients are educated on their new medications, and even how patients take and manage their medications at home.
Contact MPI Today for Personal Assistance
MPI’s Drug Master File provides speed-to-market regulatory and technical support related to our packaging components for medical and pharmaceutical market clients